A PYMNTS Company

Antitrust Chronicle® – Killer Acquisitions

Spring 2020, Volume 2, Number 2

Dear Readers, What is a killer acquisition? The term was first employed in the pharmaceutical sector to describe acquisitions by an incumbent of a competitor that threatened to launch a blockbuster drug that would undermine its own products, with a view to shutting it down. In recent times, the term…

Read More